Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
Harvard Business Review|August 6, 1994
Finding a lasting cure for U.S. health careI S Udvarhelyi, A S Relman, G M Binder, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compoundsTrudy H Grossman, Douglas J Bartels, Steve Mullin, et al.
Experimental Eye Research|July 29, 2015
Loss of DJ-1 elicits retinal abnormalities, visual dysfunction, and increased oxidative stress in miceVera L Bonilha, Brent A Bell, Mary E Rayborn, et al.
Journal of Clinical Pharmacology|June 1, 1990
Pharmacokinetics of oral and transdermal triprolidineM V Miles, R Balasubramanian, A W Pittman, et al.
Annals of Internal Medicine|September 17, 2009
The net value of health care for patients with type 2 diabetes, 1997 to 2005Karen N Eggleston, Nilay D Shah, Steven A Smith, et al.
Vision Research|August 22, 2024
Acute ocular hypertension in the living human eye: Model description and initial cellular responses to elevated intraocular pressureChristopher A Girkin, Ryan G Strickland, McKenna M Somerville, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyraseSteven M Ronkin, Michael Badia, Steve Bellon, et al.
JAMA Network Open|May 7, 2026
Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical TrialPeter S Hendricks, Sara N Lappan, Richard C Shelton, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|May 11, 2013
Biological and biomechanical responses to traditional epithelium-off and transepithelial riboflavin-UVA CXL techniques in rabbitsBrian K Armstrong, Michelle P Lin, Matthew R Ford, et al.
Pageof 29